PUBLISHER: TechNavio | PRODUCT CODE: 2109564
PUBLISHER: TechNavio | PRODUCT CODE: 2109564
Global Animal Sedative Market 2026-2030
The global animal sedative market is forecasted to grow by USD 197716.4 thousand during 2025-2030, accelerating at a CAGR of 5.5% during the forecast period. The report on the global animal sedative market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing pet humanization and advanced veterinary care, intensification of livestock production and growing emphasis on animal welfare, continuous pharmaceutical innovation and product development.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 5.2% |
| CAGR | 5.5% |
| Incremental Value | $197716.4 thousand |
Technavio's global animal sedative market is segmented as below:
By Type
- Parenteral
- Oral
By Animal Type
- Companion animals
- Farm animals
- Exotic animals
- Laboratory animals
By Application
- Surgical procedures
- Diagnostic procedures
- Euthanasia
- Others
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the emergence of less invasive and user-friendly drug delivery systems as one of the prime reasons driving the global animal sedative market growth during the next few years. Also, development of species-specific formulations and reversible agents and integration into behavioral medicine and multimodal analgesia will lead to sizable demand in the market.
The report on the global animal sedative market covers the following areas:
- Global animal sedative market sizing
- Global animal sedative market forecast
- Global animal sedative market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global animal sedative market vendors that include Alfasan International B.V., Animalcare Group PLC, Ashish Life Science Pvt. Ltd., Bimeda Holdings Ltd., Boehringer Ingelheim GmbH, Ceva Sante Animale, Chanelle Pharma Group, Dechra Pharmaceuticals Plc, Elanco Animal Health Inc., Interchemie Werken De Adelaar, Kela NV, LIVISTO Group, MSD Animal Health, Orion Corp., Ourofino SA, Vetoquinol SA, Virbac Group, VMD NV, Zoetis Inc.. Also, the global animal sedative market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Animal Type
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
- 5.1 Global Animal Sedative Market 2020 - 2024
- Historic Market Size - Data Table on Global Animal Sedative Market 2020 - 2024 ($ thousand)
- 5.2 Type segment analysis 2020 - 2024
- Historic Market Size - Type Segment 2020 - 2024 ($ thousand)
- 5.3 Animal Type segment analysis 2020 - 2024
- Historic Market Size - Animal Type Segment 2020 - 2024 ($ thousand)
- 5.4 Application segment analysis 2020 - 2024
- Historic Market Size - Application Segment 2020 - 2024 ($ thousand)
- 5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ thousand)
- 5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ thousand)
6 Qualitative Analysis
- 6.1 Impact of AI on Global Animal Sedative Market
- 6.2 Impact of Geopolitical Conflicts on Global Animal Sedative Market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
8 Market Segmentation by Type
- 8.1 Market segments
- 8.2 Comparison by Type
- 8.3 Parenteral - Market size and forecast 2025-2030
- 8.4 Oral - Market size and forecast 2025-2030
- 8.5 Market opportunity by Type
- Market opportunity by Type ($ thousand)
9 Market Segmentation by Animal Type
- 9.1 Market segments
- 9.2 Comparison by Animal Type
- 9.3 Companion animals - Market size and forecast 2025-2030
- 9.4 Farm animals - Market size and forecast 2025-2030
- 9.5 Exotic animals - Market size and forecast 2025-2030
- 9.6 Laboratory animals - Market size and forecast 2025-2030
- 9.7 Market opportunity by Animal Type
- Market opportunity by Animal Type ($ thousand)
10 Market Segmentation by Application
- 10.1 Market segments
- 10.2 Comparison by Application
- 10.3 Surgical procedures - Market size and forecast 2025-2030
- 10.4 Diagnostic procedures - Market size and forecast 2025-2030
- 10.5 Euthanasia - Market size and forecast 2025-2030
- 10.6 Others - Market size and forecast 2025-2030
- 10.7 Market opportunity by Application
- Market opportunity by Application ($ thousand)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 North America - Market size and forecast 2025-2030
- 12.3.1 US - Market size and forecast 2025-2030
- 12.3.2 Canada - Market size and forecast 2025-2030
- 12.3.3 Mexico - Market size and forecast 2025-2030
- 12.4 Europe - Market size and forecast 2025-2030
- 12.4.1 Germany - Market size and forecast 2025-2030
- 12.4.2 UK - Market size and forecast 2025-2030
- 12.4.3 France - Market size and forecast 2025-2030
- 12.4.4 Italy - Market size and forecast 2025-2030
- 12.4.5 Spain - Market size and forecast 2025-2030
- 12.4.6 The Netherlands - Market size and forecast 2025-2030
- 12.5 Asia - Market size and forecast 2025-2030
- 12.5.1 China - Market size and forecast 2025-2030
- 12.5.2 Japan - Market size and forecast 2025-2030
- 12.5.3 India - Market size and forecast 2025-2030
- 12.5.4 South Korea - Market size and forecast 2025-2030
- 12.5.5 Indonesia - Market size and forecast 2025-2030
- 12.5.6 Thailand - Market size and forecast 2025-2030
- 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 12.6.1 Brazil - Market size and forecast 2025-2030
- 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
- 12.6.3 UAE - Market size and forecast 2025-2030
- 12.6.4 Turkey - Market size and forecast 2025-2030
- 12.6.5 Argentina - Market size and forecast 2025-2030
- 12.6.6 South Africa - Market size and forecast 2025-2030
- 12.6.7 Colombia - Market size and forecast 2025-2030
- 12.6.8 Israel - Market size and forecast 2025-2030
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ thousand)
- Data Tables on Market opportunity by geography ($ thousand)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Increasing pet humanization and advanced veterinary care
- Intensification of livestock production and growing emphasis on animal welfare
- Continuous pharmaceutical innovation and product development
- 13.2 Market challenges
- Stringent and divergent regulatory approval processes
- High cost of development and limited return on investment
- Increasing public scrutiny and demand for alternatives
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 13.4 Market opportunities
- Emergence of less invasive and user-friendly drug delivery systems
- Development of species-specific formulations and reversible agents
- Integration into behavioral medicine and multimodal analgesia
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 Alfasan International B.V.
- Alfasan International B.V. - Overview
- Alfasan International B.V. - Product / Service
- Alfasan International B.V. - Key offerings
- SWOT
- 15.5 Animalcare Group PLC
- Animalcare Group PLC - Overview
- Animalcare Group PLC - Business segments
- Animalcare Group PLC - Key offerings
- Animalcare Group PLC - Segment focus
- SWOT
- 15.6 Ashish Life Science Pvt. Ltd.
- Ashish Life Science Pvt. Ltd. - Overview
- Ashish Life Science Pvt. Ltd. - Product / Service
- Ashish Life Science Pvt. Ltd. - Key offerings
- SWOT
- 15.7 Bimeda Holdings Ltd.
- Bimeda Holdings Ltd. - Overview
- Bimeda Holdings Ltd. - Product / Service
- Bimeda Holdings Ltd. - Key offerings
- SWOT
- 15.8 Boehringer Ingelheim GmbH
- Boehringer Ingelheim GmbH - Overview
- Boehringer Ingelheim GmbH - Product / Service
- Boehringer Ingelheim GmbH - Key offerings
- SWOT
- 15.9 Ceva Sante Animale
- Ceva Sante Animale - Overview
- Ceva Sante Animale - Product / Service
- Ceva Sante Animale - Key offerings
- SWOT
- 15.10 Dechra Pharmaceuticals Plc
- Dechra Pharmaceuticals Plc - Overview
- Dechra Pharmaceuticals Plc - Product / Service
- Dechra Pharmaceuticals Plc - Key offerings
- SWOT
- 15.11 Elanco Animal Health Inc.
- Elanco Animal Health Inc. - Overview
- Elanco Animal Health Inc. - Product / Service
- Elanco Animal Health Inc. - Key offerings
- SWOT
- 15.12 MSD Animal Health
- MSD Animal Health - Overview
- MSD Animal Health - Product / Service
- MSD Animal Health - Key offerings
- SWOT
- 15.13 Orion Corp.
- Orion Corp. - Overview
- Orion Corp. - Product / Service
- Orion Corp. - Key offerings
- SWOT
- 15.14 Ourofino SA
- Ourofino SA - Overview
- Ourofino SA - Product / Service
- Ourofino SA - Key offerings
- SWOT
- 15.15 Vetoquinol SA
- Vetoquinol SA - Overview
- Vetoquinol SA - Business segments
- Vetoquinol SA - Key offerings
- Vetoquinol SA - Segment focus
- SWOT
- 15.16 Virbac Group
- Virbac Group - Overview
- Virbac Group - Business segments
- Virbac Group - Key offerings
- Virbac Group - Segment focus
- SWOT
- 15.17 VMD NV
- VMD NV - Overview
- VMD NV - Product / Service
- VMD NV - Key offerings
- SWOT
- 15.18 Zoetis Inc.
- Zoetis Inc. - Overview
- Zoetis Inc. - Business segments
- Zoetis Inc. - Key offerings
- Zoetis Inc. - Segment focus
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
